Outlook Therapeutics
Outlook Therapeutics is a New Jersey-based biopharmaceutical company that develops and commercializes bevacizumab-based medicinal drugs for the treatment of retinal diseases.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Outlook Therapeutics Information
Geographic Data
Address: 485 Route 1 South
City: Monmouth Junction
State: NJ
Zip: 08830
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$202M
Social
Metrics
2,028,953Website Global Rank
8,322Website Monthly Traffic
Twitter Followers
Description
Outlook Therapeutics is a New Jersey-based biopharmaceutical company that develops and commercializes bevacizumab-based medicinal drugs for the treatment of retinal diseases.
Contact Phone:
+16096193990
Contact Email:
Outlook Therapeutics went public on 5/13/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/13/2016
Ticker Symbol:
OTLK
IPO Price:
$6/share
Amount Raised:
$35M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
